Glioblastoma-derived extracellular vesicles modify the phenotype of monocytic cells

International Journal of Cancer

Volumn 137, Issue 7, 2015, Pages 1630-1642

  De Vrij, Jeroen ^a   Niek Maas, S L ^a   Kwappenberg, Kitty M C ^b   Schnoor, Rosalie ^a   Kleijn, Anne ^c   Dekker, Lennard ^c   Luider, Theo M ^c   De Witte, Lot D ^a,d   Litjens, Manja ^a   Van Strien, Miriam E ^a   Hol, Elly M ^a,e,f   Kroonen, Jerome ^a   Robe, Pierre A ^a   Lamfers, Martine L ^c   Schilham, Marco W ^b   Broekman, Marike L D ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^f UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

exosome; extracellular vesicle; glioblastoma; macrophage; microglia; microvesicle; monocyte

Indexed keywords

CELL MARKER; GAMMA INTERFERON; INTERLEUKIN 6; MATRIX METALLOPROTEINASE 14; NESTIN; RNA; VASCULOTROPIN;

ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL INTERACTION; CELL LINEAGE; CELL PHAGOCYTOSIS; CELLULAR SECRETION; CONTROLLED STUDY; CYTOKINE RELEASE; EXOSOME; EXTRACELLULAR MATRIX; GENE EXPRESSION; GLIOBLASTOMA; GLIOBLASTOMA CELL LINE; GLIOBLASTOMA STEM LIKE CELL; HUMAN; HUMAN CELL; INTERFERON PRODUCTION; LEUKOCYTE MIGRATION; MACROPHAGE; MESENCHYMAL STEM CELL; MICROGLIA; MONOCYTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOMICS; SINGLE CELL ANALYSIS; TUMOR SUPPORTIVE PHENOTYPE; UPREGULATION; BRAIN TUMOR; METABOLISM; MONONUCLEAR CELL; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

BRAIN NEOPLASMS; CELL DIFFERENTIATION; CELL LINE, TUMOR; EXOSOMES; GLIOBLASTOMA; HUMANS; LEUKOCYTES, MONONUCLEAR; MACROPHAGES; MICROGLIA; PHENOTYPE;

EID: 84943381229     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29521     Document Type: Article

References (50)

1. Stupp R, Hegi ME, Mason WP, et al., Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 2009; 10: 459-66.
2. Avril T, Vauleon E, Tanguy-Royer S, et al., Mechanisms of immunomodulation in human glioblastoma. Immunotherapy 2011; 3: 42-4.
3. Waziri A,. Glioblastoma-derived mechanisms of systemic immunosuppression. Neurosurg Clin N Am 2010; 21: 31-42.
4. da Fonseca AC, Badie B,. Microglia and macrophages in malignant gliomas: recent discoveries and implications for promising therapies. Clin Dev Immunol 2013; 2013: 264124
5. Kohanbash G, Okada H,. Myeloid-derived suppressor cells (MDSCs) in gliomas and glioma-development. Immunol Invest 2012; 41: 658-79.
6. Gustafson MP, Lin Y, New KC, et al., Systemic immune suppression in glioblastoma: the interplay between cd14+HLA-DRlo/neg monocytes, tumor factors, and dexamethasone. Neuro Oncol 2010; 12: 631-44.
7. Gabrusiewicz K, Ellert-Miklaszewska A, Lipko M, et al., Characteristics of the alternative phenotype of microglia/macrophages and its modulation in experimental gliomas. PLoS One 2011; 6: e23902
8. Ellert-Miklaszewska A, Dabrowski M, Lipko M, et al., Molecular definition of the pro-tumorigenic phenotype of glioma-activated microglia. Glia 2013; 61: 1178-90.
9. Prosniak M, Harshyne LA, Andrews DW, et al., Glioma grade is associated with the accumulation and activity of cells bearing m2 monocyte markers. Clin Cancer Res 2013; 19: 3776-86.
10. Han SJ, Zygourakis C, Lim M, et al., Immunotherapy for glioma: promises and challenges. Neurosurg Clin N Am 2013; 23: 357-70.
11. Gyorgy B, Szabo TG, Pasztoi M, et al., Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell Mol Life Sci 2011; 68: 2667-88.
12. EL Andaloussi S, Mager I, Breakefield XO, et al., Extracellular vesicles: biology and emerging therapeutic opportunities. Nat Rev Drug Discov 2013; 12: 347-57.
13. Al-Nedawi K, Meehan B, Rak J,. Microvesicles: messengers and mediators of tumor progression. Cell Cycle 2009; 8: 2014 8:
14. Bobrie A, Krumeich S, Reyal F, et al., Rab27a supports exosome-dependent and -independent mechanisms that modify the tumor microenvironment and can promote tumor progression. Cancer Res 2012; 72: 4920-30.
15. Peinado H, Aleckovic M, Lavotshkin S, et al., Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med 2012; 18: 883-91.
16. Al-Nedawi K, Meehan B, Micallef J, et al., Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells. Nat Cell Biol 2008; 10: 619-24.
17. Al-Nedawi K, Meehan B, Kerbel RS, et al., Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR. Proc Natl Acad Sci USA 2009; 106: 3794-9.
18. Skog J, Wurdinger T, van Rijn S, et al., Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 2008; 10: 1470-6.
19. Li CC, Eaton SA, Young PE, et al., Glioma microvesicles carry selectively packaged coding and noncoding RNAs which alter gene expression in recipient cells. RNA Biol 2013; 10.
20. Bronisz A, Wang Y, Nowicki MO, et al., Extracellular vesicles modulate the glioblastoma microenvironment via a tumor suppression signaling network directed by miR-1. Cancer Res 2014; 74: 738-50.
21. Post GR, Dawson G,. Characterization of a cell line derived from a human oligodendroglioma. Mol Chem Neuropathol 1992; 16: 303-17.
22. Knaan-Shanzer S, van de Watering MJ, van der Velde I, et al., Endowing human adenovirus serotype 5 vectors with fiber domains of species B greatly enhances gene transfer into human mesenchymal stem cells. Stem Cells 2005; 23: 1598-607.
23. Balvers RK, Kleijn A, Kloezeman JJ, et al., Serum-free culture success of glial tumors is related to specific molecular profiles and expression of extracellular matrix-associated gene modules. Neuro Oncol 2013; 15: 1684-95.
24. Fael Al-Mayhani TM, Ball SL, Zhao JW, et al., An efficient method for derivation and propagation of glioblastoma cell lines that conserves the molecular profile of their original tumours. J Neurosci Methods 2009; 176: 192-9.
25. Gravendeel LA, Kouwenhoven MC, Gevaert O, et al., Intrinsic gene expression profiles of gliomas are a better predictor of survival than histology. Cancer Res 2009; 69: 9065-72.
26. Thery C, Amigorena S, Raposo G, et al., Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol 2006;Chapter 3:Unit 3 22.
27. de, Vrij J, Maas SL, van Nispen M, et al., Quantification of nanosized extracellular membrane vesicles with scanning ion occlusion sensing. Nanomedicine (Lond) 2013; 8: 1443-58.
28. Maas SL, De Vrij J, Broekman ML,. Quantification and size-profiling of extracellular vesicles using tunable resistive pulse sensing. J Vis Exp 2014; e51623.
29. Dekker LJ, Zeneyedpour L, Brouwer E, et al., An antibody-based biomarker discovery method by mass spectrometry sequencing of complementarity determining regions. Anal Bioanal Chem 2011; 399: 1081-91.
30. Franceschini A, Szklarczyk D, Frankild S, et al., STRING v9.1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res 2013; 41: d808-15.
31. Woiciechowsky C, Asadullah K, Nestler D, et al., Diminished monocytic HLA-DR expression and ex vivo cytokine secretion capacity in patients with glioblastoma: effect of tumor extirpation. J Neuroimmunol 1998; 84: 164-71.
32. Ogden AT, Horgan D, Waziri A, et al., Defective receptor expression and dendritic cell differentiation of monocytes in glioblastomas. Neurosurgery 2006; 59: 902-9; discussion 9-10.
33. Markovic DS, Vinnakota K, Chirasani S, et al., Gliomas induce and exploit microglial MT1-MMP expression for tumor expansion. Proc Natl Acad Sci U S A 2009; 106: 12530-5.
34. Vinnakota K, Hu F, Ku MC, et al., Toll-like receptor 2 mediates microglia/brain macrophage MT1-MMP expression and glioma expansion. Neuro Oncol 2013; 15: 1457-68.
35. Verhaak RG, Hoadley KA, Purdom E, et al., Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, idh1, EGFR, and nf1. Cancer Cell 2010; 17: 98-110.
36. Nolte-'t Hoen EN, van der Vlist EJ, Aalberts M, et al., Quantitative and qualitative flow cytometric analysis of nanosized cell-derived membrane vesicles. Nanomedicine 2011; 8: 712-20.
37. Shao H, Chung J, Balaj L, et al., Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy. Nat Med 2012; 18: 1835-40.
38. Dragovic RA, Gardiner C, Brooks AS, et al., Sizing and phenotyping of cellular vesicles using nanoparticle tracking analysis. Nanomedicine 2011; 7: 780-8.
39. Maas SL, de Vrij J, van der Vlist EJ, et al., Possibilities and limitations of current technologies for quantification of biological extracellular vesicles and synthetic mimics. J Control Release 2015; 200: 87-96.
40. Taylor DD, Gercel-Taylor C, Lyons KS, et al., Tcell apoptosis and suppression of T-cell receptor/CD3-zeta by fas ligand-containing membrane vesicles shed from ovarian tumors. Clin Cancer Res 2003; 9: 5113 9:
41. Kim JW, Wieckowski E, Taylor DD, et al., Fas ligand-positive membranous vesicles isolated from sera of patients with oral cancer induce apoptosis of activated T lymphocytes. Clin Cancer Res 2005; 11: 1010-20.
42. Abusamra AJ, Zhong Z, Zheng X, et al., Tumor exosomes expressing fas ligand mediate cd8+ T-cell apoptosis. Blood Cells Mol Dis 2005; 35: 169-73.
43. Sasaki A, Ishiuchi S, Kanda T, et al., Analysis of interleukin-6 gene expression in primary human gliomas, glioblastoma xenografts, and glioblastoma cell lines. Brain Tumor Pathol 2001; 18: 13-21.
44. Rey-Giraud F, Hafner M, Ries CH,. In vitro generation of monocyte-derived macrophages under serum-free conditions improves their tumor promoting functions. PLoS One 2012; 7: e42656
45. Wels J, Kaplan RN, Rafii S, et al., Migratory neighbors and distant invaders: tumor-associated niche cells. Genes Dev 2008; 22: 559-74.
46. Rutledge WC, Kong J, Gao J, et al., Tumor-infiltrating lymphocytes in glioblastoma are associated with specific genomic alterations and related to transcriptional class. Clin Cancer Res 2013; 19: 4951-60.
47. Engler JR, Robinson AE, Smirnov I, et al., Increased microglia/macrophage gene expression in a subset of adult and pediatric astrocytomas. PLoS One 2012; 7: e43339
48. Butovsky O, Jedrychowski MP, Moore CS, et al., Identification of a unique TGF-beta-dependent molecular and functional signature in microglia. Nat Neurosci 2014; 17: 131-43.
49. Fabbri M, Paone A, Calore F, et al., MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response. Proc Natl Acad Sci U S A 2012; 109: E2110-6.
50. Pyonteck SM, Akkari L, Schuhmacher AJ, et al., CSF-1R inhibition alters macrophage polarization and blocks glioma progression. Nat Med 2013; 19: 1264-72.